Page last updated: 2024-10-31

metoprolol and Hyperlipemia

metoprolol has been researched along with Hyperlipemia in 9 studies

Metoprolol: A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.
metoprolol : A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1.

Research Excerpts

ExcerptRelevanceReference
"The effects of celiprolol 200 mg or 400 mg once daily on blood pressure (BP), serum lipids, plasma fibrinogen and airways function was compared with the effects of metoprolol 100 mg or 200 mg once daily in 171 patients with mild to moderate hypertension and coexistent hyperlipidaemia in a double-blind, multicentre study lasting 1 year."5.08Effect of celiprolol and metoprolol on lipids, fibrinogen and airways function in hyperlipidaemic hypertensives: a randomised double-blind long-term parallel group trial. ( Feely, J; Holden, RD; Johnston, GD; Radley, DR; Vyssoulis, G, 1995)
"Down syndrome is a genetic disorder known to cause many complications with lifelong effects."1.51Down syndrome, severe psoriasis, and increased risk for cardiovascular events. ( DʼAcunto, K; Sismour, B, 2019)

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19903 (33.33)18.7374
1990's2 (22.22)18.2507
2000's2 (22.22)29.6817
2010's2 (22.22)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sismour, B1
DʼAcunto, K1
Duan, L1
Ng, A1
Chen, W1
Spencer, HT1
Nguyen, J1
Shen, AY1
Lee, MS1
Iaccarino, G1
Trimarco, V1
Lanni, F1
Cipolletta, E1
Izzo, R1
Arcucci, O1
De Luca, N1
Di Renzo, G1
Lynch, T1
Bielmann, P2
Leduc, G2
Davignon, J1
Johnston, GD1
Vyssoulis, G1
Feely, J1
Holden, RD1
Radley, DR1
Pershad, A1
Kratzer, S1
Cooper, A1
Hitzenberger, G1

Trials

2 trials available for metoprolol and Hyperlipemia

ArticleYear
Effect of celiprolol and metoprolol on lipids, fibrinogen and airways function in hyperlipidaemic hypertensives: a randomised double-blind long-term parallel group trial.
    Journal of human hypertension, 1995, Volume: 9, Issue:2

    Topics: Adult; Aged; Blood Pressure; Celiprolol; Double-Blind Method; Female; Fibrinogen; Heart Rate; Humans

1995
Effects of metoprolol and propranolol on lipid metabolism.
    International journal of clinical pharmacology and biopharmacy, 1979, Volume: 17, Issue:9

    Topics: Cholesterol; Double-Blind Method; Humans; Hyperlipidemias; Lipid Metabolism; Metoprolol; Propanolami

1979

Other Studies

7 other studies available for metoprolol and Hyperlipemia

ArticleYear
Down syndrome, severe psoriasis, and increased risk for cardiovascular events.
    JAAPA : official journal of the American Academy of Physician Assistants, 2019, Volume: 32, Issue:12

    Topics: Administration, Cutaneous; Adrenergic beta-Antagonists; Anti-Inflammatory Agents; Down Syndrome; Fat

2019
β-Blocker Exposure in Pregnancy and Risk of Fetal Cardiac Anomalies.
    JAMA internal medicine, 2017, 06-01, Volume: 177, Issue:6

    Topics: Adrenergic beta-Antagonists; Age Factors; Arrhythmias, Cardiac; Atenolol; Body Mass Index; Californi

2017
beta-Blockade and increased dyslipidemia in patients bearing Glu27 variant of beta2 adrenergic receptor gene.
    The pharmacogenomics journal, 2005, Volume: 5, Issue:5

    Topics: Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-3 Receptor Antagonists; Adrenergic beta-Anta

2005
Medication costs as a primary cause of nonadherence in the elderly.
    The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists, 2006, Volume: 21, Issue:2

    Topics: Aged; Anticholesteremic Agents; Antihypertensive Agents; Atorvastatin; Coronary Disease; Costs and C

2006
[Selective beta blockaders (metoprolol) versus non selective (propranolol): comparative effects on the composition of lipoprotein fractions and on blood pressure].
    L'union medicale du Canada, 1980, Volume: 109, Issue:12

    Topics: Blood Pressure; Cholesterol; Double-Blind Method; Female; Humans; Hyperlipidemias; Hypertension; Lip

1980
Coronary revascularization and aggressive lipid lowering.
    The Journal of invasive cardiology, 1999, Volume: 11, Issue:2

    Topics: Aspirin; Atorvastatin; Coronary Stenosis; Heptanoic Acids; Humans; Hyperlipidemias; Hypertension; Hy

1999
The effects of the beta-adrenoceptor blocking agent, celiprolol, on blood lipids.
    British journal of clinical practice. Supplement, 1985, Volume: 40

    Topics: Adrenergic beta-Antagonists; Celiprolol; Humans; Hyperlipidemias; Lipoproteins; Metoprolol; Propanol

1985